Nurix Therapeutics, Inc. (NRIX) — Total Assets
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $688.13M | +2.8% |
| 2024 | $669.34M | +88.2% |
| 2023 | $355.60M | -14.7% |
| 2022 | $416.76M | -12.6% |
| 2021 | $476.77M | +20.3% |
| 2020 | $396.34M | +799.8% |
| 2019 | $44.05M | — |
| Fiscal Year | Total Assets | Change YoY |
|---|---|---|
| 2025 | $688.13M | +2.8% |
| 2024 | $669.34M | +88.2% |
| 2023 | $355.60M | -14.7% |
| 2022 | $416.76M | -12.6% |
| 2021 | $476.77M | +20.3% |
| 2020 | $396.34M | +799.8% |
| 2019 | $44.05M | — |